MARKET

VOGX

VOGX

Vogenx
NASDAQ
32.42
-0.29
-0.89%
Closed 19:30 09/14 EDT
OPEN
32.77
PREV CLOSE
32.71
HIGH
34.13
LOW
31.99
VOLUME
106.20K
TURNOVER
--
52 WEEK HIGH
35.50
52 WEEK LOW
12.95
MARKET CAP
450.82M
P/E (TTM)
-947.9532
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VOGX last week (0907-0911)?
Weekly Report · 1d ago
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
Benzinga · 4d ago
Weekly Report: what happened at VOGX last week (0831-0904)?
Weekly Report · 09/07 10:33
Primary Markets Group August IPO Update
Seeking Alpha · 09/05 06:30
Vogenx Price Target Announced at $42.00/Share by WBB Securities
Dow Jones · 09/02 19:59
WBB Securities Initiates Coverage On Vogenx with Speculative Buy Rating, Announces Price Target of $42
Benzinga · 09/02 19:49
Analysts Offer Insights on NA Companies: SpaceX (SPCX) and Vogenx, Inc. (VOGX)
TipRanks · 09/02 15:00
Vogenx initiated with a Speculative Buy at WBB Securities
TipRanks · 09/02 14:45
More
About VOGX
Vogenx, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The Company's primary objective is to advance its lead product candidate, mizagliflozin, is an orally administered, minimally absorbed small molecule drug candidate in development for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome, or GDCS. Mizagliflozin is a selective inhibitor of SGLT1, a glucose transporter present in the gastrointestinal tract responsible for transporting dietary glucose into the bloodstream. Its VGX-2857 is a novel small molecule-based product candidate that is orally available. VGX-2857 is a combination of two novel small molecules that have demonstrated the potential to aid in weight loss in one fixed dosage form.

Webull offers Vogenx stock information, including NASDAQ: VOGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VOGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VOGX stock methods without spending real money on the virtual paper trading platform.